|
Response to Mr. Stephen Barrett of MLM Watch.org
and the National Council Against Health Fraud
Recently, people conducting an Internet search on “stem cell enhancer”
were surprised to find an article by
retired psychiatrist Stephen Barrett already raising
doubts about StemEnhance and stem cell enhancers. We welcome this
opportunity to provide you with further information on StemEnhance.
Barrett provides a relatively good background history of StemEnhance and
StemTech HealthSciences (STHS). However he makes an inaccurate
rapprochement between STHS and Cell Tech. STHS nor Desert Lake
Technologies has NEVER been involved in any lawsuit about false claims.
The work done by STHS and DLT is based on science, it is completely
independent from Cell Tech, and all of our claims are solidly backed by
science.
Barrett also claims that blue-green algae based products might contain
dangerous toxins. (See below for reports on microcystin and neurotoxicity)
There is no excuse at this point in time, nearly a decade after the
industry has developed a stringent quality control program, to still
repeat such irrelevant allegations. Whereas infection of beef by E.coli is
still responsible for more than 20,000 intoxications and nearly 500 deaths
every year, whereas aflatoxin in corn, peanuts, milk products, spices and
other foodstuff have been responsible for several deaths, and whereas
shellfish toxins are still responsible for several deaths every year,
blue-green algae has been linked to no ill effect. Like any other food
ingredient, if potential contaminants like heavy metals, pesticides, and
shellfish toxins are present in quantity below levels established as safe,
then the product is deemed safe. Stating that blue-green algae may be
dangerous is akin to stating that eating a shrimp cocktail or a hamburger
at your favorite restaurant is dangerous. Such a statement reflects a lack
of scientific background and knowledge, or deceptive intent.
Barrett states that before taking any product, it is advisable to know
whether it has been proven safe and effective for its intended purpose(s),
and that with respect to StemEnhance, the following questions would have
to be answered.
Questions posed by Barrett about Stem Enhance
1.
What evidence shows that taking StemEnhance will improve anyone's health?
2.
Has any study shown that people improved their health as
a result of taking it?
3.
What evidence shows that StemEnhance is safe for
long-term use?
4.
How can users be certain that long-term use will not
cause abnormal tissue growth?
5. For whom is the product advisable?
6. Who should not take it?
1. What evidence shows that taking StemEnhance will improve
anyone's health?
Numerous studies performed by various scientific teams throughout the
world, including the National Institute of Health[1] have clearly
established that the higher the levels of circulating stem cells the
better the ability of the body to maintain optimal health. A recent
publication in the New England Journal of Medicine[2] reported that the
level of stem cells in the blood was one of the best indicators of
cardiovascular health. Elevating the number of stem cells in the blood has
been shown to improve health in many ways. [3-6] StemEnhance supports the
release of stem cells from the bone marrow and increases the number of
circulating stem cells by 25-30%, which is bound to assist the body in
maintaining optimal health.
As Mr. Barrett must know, given his claimed experience with the FDA,
that we cannot make any health claims linked to StemEnhance since it is a
dietary supplement and not a drug. Our claims are limited to structure and
function claims, which is what we have solidly documented. StemEnhance
supports the natural release of stem cells from the bone marrow, thereby
assisting the body in maintaining optimal health. We would be delighted to
publish the single patient outcomes we have documented, but they could be
construed as inferred health claims. Nevertheless, clinical studies are
currently in progress involving specific organs and system to further
document the mechanics of stem cell physiology, and these studies will be
eventually published.
2. Has any study shown that people improved their health as a
result of taking it?
Numerous empirical reports and testimonials testify to the health benefits
of taking StemEnhance. Many companies have been shut down by the FDA
because of inferred health claims linked to documentation of improvements
with various diseases. We intend to maintain our message clearly within
the boundaries of the Dietary Supplement Health and Education Act, and let
StemEnhance speaks for itself. We would be delighted to provide Mr.
Barrett with a few bottles of StemEnhance so he can see the benefits on
his own health.
Back to Top
3. What evidence shows that StemEnhance is safe for long-term use?
AFA, the raw ingredient from which StemEnhance is derived, has been on the
marketplace for more than two decades with a very good track record of
safety. A safety study in mice determined that consumption of the
equivalent of up to 2,000 AFA capsules daily led to no health problems at
all. In fact, the authors claimed that the mice receiving the highest dose
of AFA were less aggressive and looked healthier. StemEnhance is a 5:1
concentrate of AFA, and just like 5:1 concentrates of echinacea or grape
seed or ginkgo or wheat grass juice that are as safe as the whole plant
they are derived from, StemEnhance is as safe as whole AFA. StemEnhance is
to whole AFA what carrot juice is to a whole carrot.
The question may also refer to the safety of increasing the number of
circulating stem cells everyday by 25-30%. Here also the safety is
unquestionable. The normal range for the number of circulating stem cells
is between 1.2 and 5.0 stem cells per µL of blood. An increase of 30% in
the number of circulating stem cells would at most mean an increase of 1.5
cells per µL, which is well within normal physiological range. Looking at
this from a different angle, Krause et al. [7] reported that one single
stem cell was enough to reconstitute the entire hematopoietic (red blood
cell) and immune systems. If one single stem cell can do this, then the
billions of stem cells left in the bone marrow after taking StemEnhance
can maintain a healthy and strong bone marrow.
Back to Top
4. How can users be certain that long-term use will not cause
abnormal tissue growth?
The release of stem cells from the bone marrow and their migration to
tissues is a natural process that happens everyday. StemEnhance simply
supports that natural process and tips the balance toward health everyday.
StemEnhance does not do anything that the body does not already do
everyday. So far, no instances of cancer or any similar problem have ever
been observed when using in vivo natural release of stem cells from the
bone marrow. Abnormal cellular growth has only been seen when manipulating
stem cells in test tubes.
5. For whom is the product advisable?
Since StemEnhance supports the natural release of stem cells from the bone
marrow, which is turn travel throughout the body to maintain the health of
various organs and tissues. StemEnhance is the optimal daily support for
the maintenance of optimal health. It is for everyone interested in giving
their body an extra boost toward daily renewal of cells throughout the
body. It is for anyone interested in supporting his or her body’s natural
renewal system.
Back to Top
6. Who should not take it?
StemEnhance naturally contains a significant amount of vitamin K.
Therefore, anyone taking anticoagulant medication should consult their
doctor in order to adjust the medication, if necessary. StemEnhance could
also be contraindicated for anyone having a disease of the bone marrow,
though this is solely speculative and is not based on any observation of
ill effect.
AFA contains phenylethylamine (PEA), known as the “molecule of love” or
the “molecule of joy”. PEA is a natural compound made by the brain
whenever one feels content, happy. Deficiency in PEA has been linked to
problems of concentration and low mood, and oral intake of PEA has been
shown to improve these conditions. StemEnhance concentrates PEA at about
5mg/g. PEA is responsible for the immediate feeling of well-being that one
experiences after taking StemEnhance. Because of the effect of PEA in the
brain, StemEnhance could be contraindicated for people suffering from
severe manic depression.
Finally, Barrett states that “A few studies—most of them done in
laboratory animals—have shown that circulating stem cells from bone marrow
can develop into a few other types of mature cells. As far as I know,
however, no study has demonstrated that increasing the number of
circulating cells is safe or makes people healthier.” This is certainly
the most eloquent expression of Barrett’s lack of expertise in this field.
Anyone interested to see if there are only “a few studies” showing that
circulating stem cells can develop into “a few other cell types”, can
simply do a search on Medline to see the thousands of article on that
topic. Or simply refer to the study of Krause[7] in which bone marrow stem
cells were seen to become functional cells of the skin, liver, colon,
intestine, stomach, esophagus, kidney and lung. Bone marrow stem cells
have also been documented to become brain cells,[8] heart cells,[1] muscle
cells,[9] pancreatic cells[10]… virtually any cell type in the body. As to
the second statement that to Barrett’s knowledge “no study has
demonstrated that increasing the number of circulating cells makes people
healthier,” one only needs to refer to the studies by Orlic at the NIH[1]
and that of Werner et al.[2] Barrett could have done a simple search at
the NIH library with the key words “circulating stem cells healing” (PubMed)
and he could have avoided misleading people as he did.
I believe it is important for the sake of ethics and public integrity to
end this discussion by putting these comments from Stephen Barrett, as
well as all other comments by him, into a bigger context. Barrett is a
retired psychiatrist who has not had many positive comments about dietary
supplements and over the years has waged a little vendetta against
anything that comes through any Network Marketing company. He would
probably be against peanut butter if it were to be sold through an MLM. His attacks
against natural approaches such as homeopathy and herbal medicine
constituted a rather eloquent display of his ignorance.
He created the so-called National Council Against Health Fraud, which
ironically is itself rather fraudulent and misleading, as it does not
represent any objective and expert council, it does not represent any
official national organization, and it provides rather biased information.
Barrett claims to have several links with the FDA and a great expertise in
FDA matter. We will let Judge Fromholz of the California Superior Court
Case shed some light on Mr. Barrett. As stated by the Judge, Barrett’s
motives appear to be more linked to personal financial gain than generous
public education.
Below is an excerpt from Judges decision rendered against NCAHF 12/17/01
by Judge Framholz in California Superior Court. You can read the complete
transcript, "A Judges View of the Quackbusters"
Back to Top
“Dr. Barrett was offered on several issues by the Plaintiff, but the
Court found that there was substantial overlap on the issues that he and
Dr. Sampson were asked to address. “Thus, in order to avoid duplicative or
cumulative evidence (see Cal. Evidence Code §§ 352, 411, 723), Dr.
Barrett's testimony was limited by the Court to the sole issue of FDA
treatment of homeopathic drugs. The relevancy of this issue was
questionable at best, since the Plaintiff had previously asserted that its
case did not depend on or seek to establish any violation of federal food
and drug laws or regulations. Nevertheless, Plaintiff elicited testimony
from Dr. Barrett on his experience with the FDA as it relates to
regulation of homeopathic drugs.
“Dr. Barrett was a psychiatrist who retired in or about 1993, at which
point he contends he allowed his medical license to lapse. Like Dr.
Sampson, he has no formal training in homeopathic medicine or drugs,
although he claims to have read and written extensively on homeopathy and
other forms of alternative medicine. Dr. Barrett's claim to expertise on
FDA issues arises from his conversations with FDA agents, his review of
professional literature on the subject and certain continuing education
activities.
“As for his credential as an expert on FDA regulation of homeopathic
drugs, the Court finds that Dr. Barrett lacks sufficient qualifications in
this area. Expertise in FDA regulation suggests a knowledge of how the
agency enforces federal statutes and the
agency's own regulations. Dr. Barrett's purported legal and regulatory
knowledge is not apparent. He is not a lawyer, although he claims he
attended several semesters of correspondence law school. While Dr. Barrett
appears to have had several past conversations with FDA representatives,
these appear to have been sporadic, mainly at his own instigation, and
principally for the purpose of gathering information for his various
articles and Internet web-sites. He has never testified before any
governmental panel or agency on issues relating to FDA regulation of
drugs. Presumably his professional continuing education experiences are
outdated given that he has not had a current medical license in over seven
years. For these reasons, there is no sound basis on which to consider Dr.
Barrett qualified as an expert on the issues he was offered to address.
Moreover, there was no real focus to his testimony with respect to any of
the issues in this case associated with Defendants' products.
“Furthermore, the Court finds that both Dr. Sampson and Dr. Barrett are
biased heavily in favor of the Plaintiff and thus the weight to be
accorded their testimony is slight in any event. Both are long-time board
members of the Plaintiff; Dr. Barrett has served as its
Chairman. Both participated in an application to the U.S. FDA during the
early 1990s designed to restrict the sale of most homeopathic drugs. Dr.
Sampson's university course presents what is effectively a one-sided,
critical view of alternative medicine. Dr. Barrett's heavy activities in
lecturing and writing about alternative medicine similarly are focused on
the eradication of the practices about which he opines. Both witnesses'
fees, as Dr. Barrett testified, are paid from a fund established by
Plaintiff NCAHF from the proceeds of suits such as the case at bar. Based
on this fact alone, the Court may infer that Dr. Barrett and Sampson are
more likely to receive fees for testifying on behalf of NCAHF in future
cases if the Plaintiff prevails in the instant action and thereby wins
funds to enrich the litigation fund described by Dr. Barrett. It is
apparent, therefore, that both men have a direct, personal financial
interest in the outcome of this litigation. Based on all of these factors,
Dr. Sampson and Dr. Barrett can be described as zealous advocates of the
Plaintiff's position, and therefore not neutral or dispassionate witnesses
or experts. In light of these affiliations and their orientation, it can
fairly be said that Drs. Barrett and Sampson are themselves the client,
and therefore their testimony should be accorded little, if any,
credibility on that basis as well.”
Back to Top
References
[1] Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F,
Nadal-Ginard B, Bodine DM, Leri A. & Piero Anversa. (2001) Mobilized bone
marrow cells repair the infracted heart, improving function and survival.
PNAS 98(18):10344–10349.
[2] Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M,
Nickenig G. (2005) Circulating endothelial progenitor cells and
cardiovascular outcomes. N Engl J Med. 8;353(10):999-1007.
[3] Bozlar M, Aslan B, Kalaci A, Baktiroglu L, Yanat AN, Tasci A.
(2005) Effects of human granulocyte-colony stimulating factor on fracture
healing in rats. Saudi Med J. 26(8):1250-4.
[4] Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt
RE, Dzau VJ. (2004) Cytokine-induced mobilization of circulating
endothelial progenitor cells enhances repair of injured arteries.
Circulation. 110(14):2039-46.
[5] Eroglu E, Agalar F, Altuntas I, Eroglu F. (2004) Effects of
granulocyte-colony stimulating factor on wound healing in a mouse model of
burn trauma. Tohoku J Exp Med. 204(1):11-6.
[6] Tomoda H, Aoki N. Bone marrow stimulation and left ventricular
function in acute myocardial infarction. Clin Cardiol. 2003
Oct;26(10):455-7.
[7] Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner
R, Neutzel S, Sharkis SJ. (2001) Multi-organ, multi-lineage engraftment by
a single bone marrow-derived stem cell. Cell 105:369-77.
[8] Eglitis MA and Mezey VA. (1997) Hematopoietic cells differentiate
into both microglia and macroglia in the brains of adult mice. Proc. Natl.
Acad. Sci. USA Vol. 94, pp. 4080–4085.
[9] Camargo FD, Green R, Capetenaki Y, Jackson KA, and Goodell MA.
(2003) Single hematopoietic stem cells generate skeletal muscle through
myeloid intermediates. Nature 9(12):1520-27.
[10] Ianus A, Holz GG, Theise ND, and Hussain MA. (2003) In vivo
derivation of glucosecompetent cells from bone marrow without evidence of
cell fusion. J. Clin. Invest. 111:843-850.
|